Daily blood glucose and HbA1c are regularly used for monitoring glycemic control which provide short term and long term measurements. GSP is used to fill the gap between those tests by providing an accurate, reliable 2-3 week marker for glycemic control.
The Glycation Gap
Studies suggest that combining GSP results with HbA1c measurements provides a better assessment of long term risk of diabetic complications.
The difference between actual measured HbA1C and predicted HbA1c from glycated serum protein is called the glycation gap.
The Glycated Serum Protein LiquiColor Assay:
• Delivers accurate reliable results – no interference from endogenous reducing substances that affect traditional Fructosamine (NBT).
• Is specific to all glycated proteins – includes glycated albumin, glycated hemoglobin, and other glycated proteins.
• Is useful for conditions and treatments that affect RBC half-life such as Hemoglobinopathy, Iron Deficiency, End Stage Renal Disease Age and Race, Anemia, Uremia, Blood loss, Drug treatments and Pregnancy.